Position in ELAN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$952,653
+$655,730 QoQ
Shares Held
38,710
+212.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#232
of 519 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Eurizon Capital SGR S.p.A. holds $26,289,096 across 12 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
156,491 | $11,245,443 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
50,275 | $8,473,348 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,016 | $2,717,819 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
58,799 | $1,992,110 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
38,710 | $952,653 | |
| 6 | VTRS |
Viatris Inc
|
15,978 | $253,730 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
17,434 | $252,618 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,502 | $166,631 |
All Filings in ELAN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $952,653 | 38,710 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $296,923 | 12,408 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $122,383 | 5,408 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||